Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)

In article 1600202, CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to tumor cells with highly efficient anticancer and antimetastatic properties by Veronique Orian‐Rousseau, Pavel A. Levkin, and co‐workers. The modular synthesis and fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linxian, Schmitt, Mark, Matzke‐Ogi, Alexandra, Wadhwani, Parvesh, Orian‐Rousseau, Veronique, Levkin, Pavel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Cover Picture
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238733/
http://dx.doi.org/10.1002/advs.201770001
Descripción
Sumario:In article 1600202, CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to tumor cells with highly efficient anticancer and antimetastatic properties by Veronique Orian‐Rousseau, Pavel A. Levkin, and co‐workers. The modular synthesis and facile preparation makes this system highly potent for developing novel multifunctional nanocarriers for therapeutic and/or diagnostic anticancer applications. [Image: see text]

Ejemplares similares